Search Bar & Filters
Found 4 Actively Recruiting clinical trials
Actively Recruiting
This research aims to evaluate the effect of tozorakimab, given in addition to standard care, in adults hospitalized for viral lung infection who require supplemental oxygen. The study focuses on whether this treatment can prevent death or the need for invasive mechanical ventilation IMV or extracorporeal membrane oxygenation ECMO. It is a Phase III, randomized, double-blind, placebo-controlled trial assessing patients with hypoxaemia due to viral lung infection. Participants will be randomly assigned in equal numbers to one of two groups. One group will receive a single intravenous dose of tozorakimab on Day 1, while the other group will receive a matching placebo dose. Both groups will continue to receive standard care alongside the study treatment. The trial is designed to follow patients for up to 60 days to assess various clinical outcomes related to respiratory status and survival. During the study, participants will be monitored for progression to invasive ventilation or death up to 28 days as the primary outcome. Additional assessments include survival at 60 days, time spent outside the intensive care unit, days free from supplemental oxygen, and clinical progression scales. Safety evaluations include monitoring for anti-drug antibodies. The total participation time spans from treatment administration through clinical follow-up up to 60 days.
Actively Recruiting
Researchers are investigating factors associated with mortality in the intensive care unit ICU and evaluating the performance of the APACHE II score as a tool to predict mortality. The study focuses on critically ill adult patients admitted to the ICU in a hospital in Villavicencio, Colombia. It addresses the need to validate this score within a different population and healthcare setting, as current data in Colombia are limited. This observational study reviews records of all adult patients admitted to the ICU from January 2022 to June 2025, excluding those in intermediate care with lower therapeutic intervention scores. Data collected include demographic details, diagnosis, APACHE II and TISS-28 severity scores, mechanical ventilation duration, and outcomes such as mortality and ICU length of stay. Patients are grouped based on whether they died within 28 days or survived and were discharged alive within 24 days. Participants medical information is gathered retrospectively from clinical charts and entered into a standardized database. The APACHE II score is calculated within the first 24 hours of ICU admission. Researchers analyze mortality rates by disease and admission type, factors linked to mortality, and compare observed versus predicted mortality using statistical methods. The main outcome measured is mortality within 28 days, with careful monitoring of ICU stay and ventilation duration. The study is approved by an ethics committee and classified as low-risk research.
Actively Recruiting
Researchers are investigating the factors linked to severe trauma outcomes, including mortality, among patients admitted to intensive care units ICUs in general hospitals across the Colombian Orinoco region. This study focuses on trauma, the leading cause of death and disability in young populations worldwide, often caused by violence and vehicle accidents. By analyzing trauma admissions and comparing them to other ICU admissions, the study aims to identify key predictors of trauma mortality and outcomes. The study involves reviewing ICU discharge records over a two-year period from January 2022 to December 2024 at two hospitals in Villavicencio, Colombia. Patients are grouped into those admitted for trauma-related reasons and those admitted for other diagnoses. The researchers will analyze demographic data, severity scores, and diagnoses to understand differences and factors associated with trauma outcomes. Participants medical records will be examined to assess mortality within 30 days and length of ICU stay. The study will highlight causes of trauma admissions, severity, and outcomes for different trauma types. The goal is to develop a predictive model tailored to the local population to help improve resource allocation, treatment strategies, and potentially reduce mortality and complications. The study extends through 2028 and is observational, reviewing existing hospital data without direct patient intervention.
Actively Recruiting
Researchers are conducting a descriptive cross-sectional study to evaluate stroke events in a hospital located in the Orinoco region of Colombia. The study aims to analyze patient data from a stroke registry to understand care patterns, treatment delays, and adherence to clinical guidelines. This registry is reviewed monthly by a scientific committee to improve healthcare quality and standardize treatments for stroke patients. The study involves collecting demographic information, disease data, and discharge outcomes from patients admitted to the emergency room with suspected stroke based on neurological deficits or headache. Data is systematically gathered in a database called RES-Q, and the records will be reviewed and analyzed using statistical methods during the study period. The study does not include any interventions or treatments as it is observational. Participants will be adults diagnosed with stroke, whose clinical and CT findings confirm the condition. Researchers will assess the participants functional condition 30 days after the stroke event. The study relies on reviewing existing patient records and does not require active treatment or visits beyond routine care. The total study duration extends until April 2027, allowing comprehensive data collection and analysis.